GenoMed

About:

GenoMed is a Next Generation Disease Managementtm company

Website: http://www.genomedics.com/

Top Investors: Pierpoint Investissements

Description:

GenoMed is a Next Generation Disease Managementtm company that uses medical genomics to improve patient outcomes. GenoMed is working to translate knowledge of medical genomics (the study of which genes cause disease) into clinical practice: developing better drugs, using existing drugs for new indications, and identifying diseases before symptoms arise. By studying disease genes, we hope to make medicine less invasive and more proactive.

Total Funding Amount:

$21M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2001-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2004-07-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai